A landmark donation to support McGill University’s renowned genomics research and education programs from UK-based alumnus and long-time donor Victor Dahdaleh is a catalyst for advancements in genomics research. Thanks to gifts from Victor Dahdaleh totalling more than $30 million, McGill will launch the Victor Phillip Dahdaleh Institute of Genomic Medicine.
Category:
Published on: 20 Oct 2022
A Made-in-Canada data solution to support the Government of Canada Variants of Concern Strategy
Category:
Published on: 23 Mar 2021
Joint research program between the Japan Agency for Medical Research and Development and the Canadian Institutes of Health Research focuses on advancing technologies in epigenomics, deepening McGill’s relationship with Japan’s RIKEN institute.
By Junji Nishihata
Category:
Published on: 21 Dec 2020
Earlier today, a Quebec based consortium of research institutes (Génome Québec, Oncopole and IVADO) announced the winners of their first-ever “Omics Data Against Cancer” competition, and McGill research teams were dominant. In fact, of the five selected teams no less than four of them included professors from McGill.
Category:
Published on: 5 Nov 2020
The Fonds de recherche du Québec (FRQ) and Genome Québec today announced the launch of the Québec COVID-19 Biobank, a Province-wide initiative to enable the collection, storage and sharing of samples and data related to the COVID-19 crisis. The task force that has been mobilized to take on this role is led by McGill University’s Dr. Vincent Mooser, with additional medical and scientific expertise from McGill and several other Quebec institutions. The Biobank will begin operations on April 1, 2020.
Category:
Published on: 27 Mar 2020
An international team, that includes researchers from McGill, has completed the most comprehensive study of whole cancer genomes to date, significantly improving our fundamental understanding of cancer and signposting new directions for its diagnosis and treatment.
Category:
Published on: 5 Feb 2020
McGill University Professor Bartha Knoppers, a global leader in the study of legal, social and ethical issues related to biomedical research in human genetics and genomics, has been awarded the 2019 Henry G. Friesen International Prize in Health Research by the Friends of Canadian Institutes of Health Research (FCIHR).
Category:
Published on: 19 Mar 2019
Major federal and provincial investments in genomics research were announced this week following three recent Genome Canada competitions. The announcement, made at University of Guelph, includes over $10 million in funding to seven projects led by McGill researchers. Here's a quick look at one of those projects. (A complete list follows.)
Category:
Published on: 5 Feb 2019
Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.
Category:
Published on: 4 Feb 2019
EpiShare will join the Global Alliance for Genomics and Health (GA4GH) as a 2019 Driver Project. GA4GH, an international group of 22 leading genomic data initiatives, works collaboratively to develop and pilot standards for sharing genomic and health-related data.
“EpiShare represents a unique opportunity to contribute to the field of epigenomics by extending global standards and tools, which have so far been developed only for genetic and genomic information.” --Guillaume Bourque, Project Champion and Associate Professor of Human Genetics at McGill University.
Category:
Published on: 4 Feb 2019
In the wake of the announcement in China last November of the first ‘CRISPR babies’, Prof. Bartha Knoppers and researcher Erika Kleiderman from McGill’s Centre of Genomics and Policy (CGP) have published a commentary article in the Canadian Medical Association Journal on the use of CRISPR gene-editing techniques.
Category:
Published on: 28 Jan 2019
A patient develops a rare condition and needs answers, so their clinician searches frantically to find patients with similar, rare, symptoms and similar possible causes. To understand the mechanisms of one debilitating disease, a medical researcher tries to separate the “signal” of causes of that disease, in particular, from the “noise” of natural biological variation of human lives and conditions.
Category:
Published on: 24 Jan 2019
McGill University has helped develop a global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes. The BRCA Exchange was created through the BRCA Challenge, a long-term demonstration project initiated by the Global Alliance for Genomics and Health (GA4GH) to enhance sharing of BRCA1/BRCA2 data.
Category:
Published on: 9 Jan 2019
A ground-breaking new study led by researchers from the Lady Davis Institute (LDI) at the Jewish General Hospital (JGH) has succeeded in compiling an atlas of genetic factors associated with estimated bone mineral density (BMD), one of the most clinically relevant factors in diagnosing osteoporosis. The paper, published in Nature Genetics, identifies 518 genome-wide loci, of which 301 are newly discovered, that explain 20% of the genetic variance associated with osteoporosis.
Category:
Published on: 3 Jan 2019
Pioneering work to advance genomics and precision health treatments at the Research Institute of the McGill University Health Centre (RI-MUHC) has been rewarded by Génome Québec. Dr. Nada Jabado and Dr. Ruth Sapir-Hichhadze, the RI-MUHC scientists who received the reward, were among the winners of a nation-wide competition emphasizing precision treatments in genomics.
Category:
Published on: 25 Apr 2018
Pages
